Tower Research Capital LLC (Trc) Ideaya Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,390 shares of IDYA stock, worth $109,442. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,390
Previous 14,953
70.64%
Holding current value
$109,442
Previous $524,000
73.47%
% of portfolio
0.0%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding IDYA
# of Institutions
215Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$170 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$130 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$129 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$120 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$100 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.2B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...